NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

UltraTech Cement Surpasses Estimates in 4QFY26

UltraTech Cement, a leading cement manufacturer, has released its financial results for the fourth quarter of fiscal year 2026, exceeding the expectations of Motilal Oswal's research team. The company's 4QFY26 EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was significantly higher than the estimated value, driven by lower operational expenses per ton.

According to the research report, UltraTech Cement's consolidated EBITDA increased by approximately 21% year-over-year to INR56.0 billion, marking a 7% beat against the estimated value. Additionally, the company's EBITDA per ton grew by around 11% year-over-year to INR1,253, surpassing the estimated value of INR1,148. The operating profit margin (OPM) surged by 1.7 percentage points year-over-year to approximately 22%, outperforming the estimated value by 1.8 percentage points.

Financial Highlights

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Metric4QFY26 Actual4QFY26 Estimated
Consolidated EBITDAINR56.0 billion-
EBITDA per tonINR1,253INR1,148
OPM22%20.3%

The adjusted profit after tax (PAT) grew by around 20% year-over-year to INR29.9 billion, a 10% beat against the estimated value. Motilal Oswal's research team has maintained a positive outlook for the company, valuing UltraTech Cement at 18x FY28E EV/EBITDA, which translates to a target price of INR13,800. The stock is currently trading at 19x/16x FY27E/FY28E EV/EBITDA.

In light of these financial results, Motilal Oswal reiterates its BUY recommendation for UltraTech Cement.

Investor Takeaway

Investors should consider buying UltraTech Cement, targeting a price of Rs 13,800.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.